Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.590
+0.020 (1.27%)
At close: Nov 6, 2026, 4:00 PM EST
1.600
+0.010 (0.63%)
After-hours: Nov 6, 2026, 6:19 PM EST
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $68.14 million as of November 6, 2026. It is the 27,694th most valuable company in the world and the 4,360th biggest in the United States. Its market cap has increased by 6.71% in one year.
Market Cap
68.14M
Enterprise Value
-19.71M
1-Year Change
6.71%
Global Rank
Country Rank
#4,360 United States
Category
ChartMarket Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $68.14M, a decrease of -71.02%. That is a compound annual growth rate of -26.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 68.99M | -9.28% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 82.28M |
| Rani Therapeutics Holdings | 80.93M |
| NeOnc Technologies Holdings | 78.55M |
| Nutriband | 73.54M |
| OKYO Pharma | 72.95M |
| MediciNova | 72.36M |
| Coya Therapeutics | 71.90M |
| Corbus Pharmaceuticals Holdings | 69.24M |